Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3521-3527

  Herold, Kevan C ^a   Vezys, Vaiva ^a   Sun, Qin ^a   Viktora, Daiva ^a   Seung, Edward ^a   Reiner, Steve ^a   Brown, Daniel R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; STREPTOZOCIN DIABETES;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-4; ISLETS OF LANGERHANS; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; STREPTOZOCIN;

EID: 0029949222     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Rabinovitch, A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43: 613.
2. Sarvetnick, N., J. Shizuru, D. Liggin, L. Martin, B. McIntyre, A. Gregory, T. Parslow, and T. Stewart. 1990. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 346:844.
3. Higuchi, Y., P. Herrara, P. Muniesa, J. Huarte, D. Belin, P. Ohashi, P. Aichele, L. Orci, J. D. Vassalli, and P. Vassalli. 1992. Expression of tumor necrosis alpha transgene in murine pancreatic beta cells results in severe and persistent insulins without evolution towards diabetes. J. Exp. Med. 176:1719.
4. Picarella, D. E., A. Kratz, C.-B. Li, N. H. Ruddle, and R. A. Flavell. 1992. Insulitis in transgenic mice expression tumor necrosis factor β (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA 89:10036.
5. Picarella, D. E., A. Kratz, C.-B. Li, N. H. Ruddle, and R. A. Flavell. 1993. Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulins, not diabetes. J. Immunol. 150:4136.
6. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
7. Fitch, F. W., M. D. McKisic, D. W. Lancki, and T. F. Gajewski. 1993. Differentiation regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29.
8. + T cell clones can provide B cell help. J. Immunol. 154:3118.
9. Scott, B., R. Liblau, S. Degermann, L. A. Marconi, L. Ogata, A. J. Caton, H. O. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73.
10. Campbell, I. L., L. Oxbrow, M. Koulmanda, and L. C. Harrison. 1988. IFN-γ induces islet cell MHC antigens and enhances autoimmune streptozotocin-induced diabetes in the mouse. J. Immunol. 140:1111.
11. Cockfield, S. M., V. Ramassar, J. Urmson, and P. F. Halloran. 1989. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-γ. J. Immunol. 142:1120.
12. Campbell, I. L., T. W. H. Kay, L. Oxbrow, and L. C. Harrison. 1991. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:739.
13. Debray-Sachs, M., C. Camaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa, and J.-F. Bach. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J. Autoimmun. 4:237.
14. Sadelain, M. W., H.-Y. Win, J. Lauzon, and B. Singh. 1990. Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:583.
15. Shehadeh, N. N., F. LaRosa, and K. J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:291.
16. Pennline, K. J., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:169.
17. Rapoport, M. H., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferation unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87.
18. Katz, J., C. Boniest, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185.
19. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
20. Serreze, D. V., K. Hamaguchi, and E. H. Leiter. 1989. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759.
21. Wogensen, L., X. Huang, and N. Sarvetnick. 1993. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J. Exp. Med. 178:175.
22. Wogensen, L., M.-S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179:1379.
23. Huang, X., J. Yuan, A. Goddard, A. Foulis, R. F. L. James, A. Lemmark, R. Pujol-Borrell, A. Rabinovitch, N. Somoza, and T. A. Stewart. 1995. Interferon expression in the pancreases of patients with type 1 diabetes. Diabetes 44:658.
24. Herold, K. C., A. G. Montag, S. M. Meyer, C. Wojcikowski, and F. W. Fitch. 1990. Expression of Ly-6C by T lymphocytes of NOD mice after CD3-complex stimulation. Diabetes 39:815.
25. Leiter, E. H., and D. V. Serreze. 1991. Autoimmune diabetes in the nonobese diabetic mouse: suppression of immune defects by bone marrow transplantation and implications for therapy. Clin. Immunol. Immunopathol. 59:323.
26. Serreze, D. V., H. R. Gaskins, and E. H. Leiter. 1993. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol. 150: 2534.
27. Like, A. A., A. C. Appel, M. Williams, and A. A. Rossini. 1978. Streptozotocin-induced pancreatic insulitis in mice. Lab. Invest. 38(Suppl. 4):470.
28. Like, A. A., and A. A. Rossini. 1976. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415.
29. Kolb, H. 1993. IDDM: Lessons from the low-dose streptozocin model in mice. Diabetes Reviews 1:116.
30. Herold, K. C., A. G. Montag, and F. W. Fitch. 1987. Treatment with anti-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozotocin. Diabetes 36:796.
31. Herold, K. C., J. A. Bluestone, A. G. Montag, A. Parihar, A. Wiegner, R. E. Gress, and R. Hirsch. 1992. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody. Diabetes 41:385.
32. Herold, K. C., A. G. Montag, and F. Buckingham. 1992. Induction of tolerance to autoimmune diabetes with islet antigens. J. Exp. Med. 176:1107.
33. Somoza, N., F. Vargas, C. Roura-Mir, M. Vives-Pi, M. T. Fernandez-Figueras, A. Ariza, R. Gomis, R. Bragado, M. Marti, D. Jaraquemada, and R. Pujol-Borrell. 1994. Pancreas in recent onset insulin-dependent diabetes mellitus. J. Immunol. 153:1360.
34. Itoh, N., T. Hanafusa, A. Miyazaki, H. Miyagawa, K. Yamagata, K. Yamamoto, M. Waguri, A. Imagawa, S. Tamura, M. Inada, S. Kawata, S. Tarui, N. Kono, and Y. Natsuzawa. 1993. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 92:2313.
35. Elder, M., and N. Maclaren. 1983. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J. Immunol. 130:1723.
36. Spiltany, G. L., and E. A. Havell. 1984. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 159:1560.
37. Zurawski, S. M., T. R. Mosmann, M. Benedik, and G. Zurawski. 1986. Alterations in the amino-terminal third of mouse interleukin 2: effects on biological activity and immunoreactivity. J. Immunol. 137:3354.
38. Lowenthal, J. W., P. Corthesy, C. Tougne, R. Lees, H. R. MacDonald, and M. Mabholz. 1985. High and low affinity IL-2 receptors: analysis by IL-2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J. Immunol. 135:3988.
39. O'Hara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulating factor-1. Nature 315:333.
40. Newell, K. A., J. D. Ellenhorn, D. S. Bruce, and J. A. Bluestone. 1991. In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc. Natl. Acad. Sci. USA 88:1074.
41. Reiner, S., S. Zheng, D. Corry, and R. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37.
42. + T cells during initiation of infection. J. Exp. Med. 179:447.
43. Wynn, T., I. Eltoum, A. Cheever, F. Lewis, W. Gause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430.
44. Leo, O., M. Foo, D. H. Sachs, L. E. Samuelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
45. + T-cells. Diabetes 44:354.
46. Kolb-Bachofen, V., S. Epstein, U. Kiesel, and H. Kolb. 1988. Low dose streptozocin-induced diabetes in mice: electron microscopy reveals single cell insulitis before diabetes onset. Diabetes 37:21.
47. Fitch, F. W., R. Stack, P. Fields, D. W. Lancki, and D. C. Cronin, II. 1996. Regulation of T lymphocyte subsets. Immunol. Rev. In press.
48. Bonnevie-Nielsen, V., M. W. Steffes, and A. Lernmark. 1981. A major loss in islet mass and β-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 30:424.
49. Huang, X., B. Hultgren, N. Bybdal, and T. Stewart. 1994. Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 1:469.
50. Hatamori, N., K. Yokono, M. Hayakawa, T. Taki, W. Ogawa, M. Nagata, J. Hari, K. Shii, H. Taniguchi, and S. Baba. 1990. Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice. Diabetologia 33: 266.